Mohammad Shahangir Biswas | Cellular Toxicity | Best Researcher Award

Published on by Cell Biologist

Dr. Mohammad Shahangir Biswas | Cellular Toxicity | Best Researcher Award

Dr. Mohammad Shahangir Biswas | University of Science & Technology Chittagong | Bangladesh

Dr. Mohammad Shahangir Biswas is a distinguished academician and researcher in the fields of Biochemistry, Biotechnology, and Public Health, currently serving as an Assistant Professor at the University of Science and Technology Chittagong (USTC), Bangladesh. He worked as a Postdoctoral Research Associate at the University of Wisconsin-Madison, USA. His academic and research journey reflects a dedication to global health issues, molecular biology, and neurophysiology. Previously, he served as Assistant Professor at Khwaja Yunus Ali University. He has co-authored more than 48 scientific publications, including multiple first-author articles in The Lancet and other Q1 journals. With international exposure and extensive research collaborations, he brings a strong commitment to scientific excellence. Dr. Biswas is fluent in English, speaks Japanese (basic), and is a native speaker of Bangla. He is passionate about public health advancement, biomedical research, and mentoring the next generation of scientists.

Publication Profiles:

Scopus
Orcid

Education:

Dr. Biswas earned his Ph.D. in Biochemistry/Medical Science from Tokyo Medical and Dental University, supported by the prestigious MEXT Scholarship. He later completed a Postdoctoral Fellowship at the University of Wisconsin-Madison, USA, contributing to advanced research in public health and neurophysiology. Prior to his doctoral studies, he obtained his M.Sc. (Thesis) and B.Sc. (Hons.) degrees in Biochemistry and Molecular Biology from the University of Rajshahi, Bangladesh. His early academic excellence earned him multiple scholarships and positioned him for a strong career in scientific research. This strong educational foundation, combined with global exposure, has equipped him with expertise in molecular biology, public health research, and biotechnological innovation. Dr. Biswas continues to use his academic training to lead impactful research, particularly in disease burden analysis and biomedical therapeutics.

Experience:

Dr. Mohammad Shahangir Biswas brings a diverse academic and research background spanning over a decade. He served as Assistant Professor at Khwaja Yunus Ali University and later joined USTC as Assistant Professor, soon to be active as an Associate Professor. He conducted impactful postdoctoral research at the University of Wisconsin-Madison, contributing to global public health research initiatives. His teaching and research cover Biochemistry, Biotechnology, Neurophysiology, and Public Health. In addition to his teaching roles, Dr. Biswas is a Senior Collaborator in the Global Burden of Disease (GBD) Study, contributing to several high-impact international publications. His strong leadership, grant acquisition, and mentoring skills have made him an influential figure in Bangladesh’s biomedical research landscape. He remains dedicated to fostering collaborative research and academic excellence both locally and internationally.

Awards and Honors:

Dr. Biswas has received numerous awards and recognitions throughout his academic journey. Notably, he was awarded the Japanese MEXT Scholarship for his Ph.D. studies in Japan—a highly competitive and prestigious international award. His undergraduate and postgraduate achievements at the University of Rajshahi were recognized with merit-based scholarships. Additionally, he received an R&D Grant from the Ministry of Science and Technology, Bangladesh, for conducting impactful research. His research contributions to major international collaborations such as the Global Burden of Disease Study have further established his credibility and excellence in global health research. His work has been accepted in top-tier journals including The Lancet and JACC, cementing his role as a leading researcher from Bangladesh on the global stage. These honors reflect his dedication, academic brilliance, and contributions to advancing medical science, especially in the fields of public health, neurodegeneration, and biochemistry.

Research Focus:

Dr. Shahangir Biswas’s research focuses on the molecular basis of disease, global health burden, neurodegeneration, and biomedical intervention strategies. He has contributed significantly to the Global Burden of Disease (GBD) Study, publishing extensively on cancer, cardiovascular diseases, and immunization trends. His work integrates biochemistry, biotechnology, and public health, aiming to identify mechanistic pathways of diseases like Alzheimer’s and tuberculosis, and develop therapeutic interventions. Additionally, he explores snake venom biochemistry, vaccine development, and the impact of social factors such as social media on mental health. Dr. Biswas is passionate about interdisciplinary research combining molecular diagnostics, bioinformatics, and global epidemiological data. His current work includes identifying biomarkers, assessing toxicology impacts, and predicting future disease trends using large-scale datasets. With over 48 peer-reviewed publications, he maintains a strong collaboration network internationally and is a vocal advocate for translational research that informs policy and clinical practice.

Publications Top Notes: 

  1. The global, regional, and national burden of cancer, 1990–2023 – The Lancet

  2. The global burden of cancer: Forecasts to 2050 – The Lancet, Accepted

  3. Global trends in childhood vaccination coverage 1980–2023 – The Lancet, Accepted

  4. Burden of Cardiovascular Diseases in 204 countries (1990–2023) – JACC, Accepted

  5. Biochemical Profile of Bangladeshi Russell’s Viper Venom – Journal of Toxicology, Accepted

  6. Neurodegeneration in Alzheimer’s Disease: Mechanisms and Therapies – Advanced Neurology, Accepted

  7. Musculoskeletal Extrapulmonary TB in Lagos, Nigeria – Health Sci Rep, Accepted

  8. Cytokines and Vascular Inflammation in Viral Infections – Health Sci Rep, Accepted 2

  9. Social Media and Mental Health of Young Adults in Bangladesh – Health Sci Rep, Accepted

  10.  Emerging Evidence on HKU5-CoV-2 – Romanian Journal of Infectious Diseases

Conclusion:

In conclusion, Dr. Mohammad Shahangir Biswas is a highly suitable candidate for the Best Researcher Award, given his consistent and impactful contributions to biomedical and public health research, his impressive publication record in world-renowned journals, and his strong academic foundation. He has demonstrated a deep commitment to advancing scientific knowledge with global relevance and interdisciplinary reach. With continued strategic focus on leadership roles in research, mentorship, and innovation, Dr. Biswas is well-positioned not only to receive this award but also to make even greater contributions to science and society in the years ahead.

ALINE TAKEJIMA | Tissue engineering | Women Researcher Award

Published on by Cell Biologist

Dr. ALINE TAKEJIMA | tissue engineering | Women Researcher Award

Dr. ALINE TAKEJIMA, pontificia universidade catolica do parana, Brazil

Dr. Aline Luri Takejima is a physician-scientist from Brazil, specializing in regenerative medicine and wound healing. She holds an MD and a PhD in Health Sciences from the Pontifical Catholic University of Paraná (PUCPR), where she currently conducts postdoctoral research. With a focus on biological therapies involving the amniotic membrane, Wharton’s jelly, and mononuclear stem cells, Dr. Takejima has published in multiple high-impact scientific journals. Her research aims to develop novel regenerative strategies to treat complex wounds and enhance tissue repair. As an active member of PUCPR’s Wound Healing Research Group and the Brazilian Society of Plastic Surgery, she combines scientific rigor with clinical insight to bridge bench-to-bedside innovation. Her academic contributions are guided by a translational approach, offering promising avenues for future clinical applications in tissue engineering.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Focused Research Excellence:
    Dr. Takejima’s work on biological scaffolds and stem cells in wound healing is both innovative and clinically relevant. Her studies using amniotic membrane, Wharton’s jelly, and bone marrow mononuclear cells show promising regenerative outcomes in preclinical models.

  2. Research Productivity:
    With 9 peer-reviewed journal articles in high-quality platforms (e.g., Biomedicines, Tissue Barriers, Annals of Biomedical Engineering), she demonstrates consistent academic output in her field.

  3. Translational Impact:
    Her research bridges basic science and clinical practice, aiming to provide regenerative solutions for patients with chronic wounds and cardiac damage.

  4. Collaborative Engagement:
    Active participation in a multidisciplinary wound healing research group, contributing to cross-functional scientific advancements.

  5. Recognition Potential:
    As a young, emerging woman researcher in biomedical sciences, she stands as a role model for future female scientists in Latin America and beyond.

🔧 Areas for Improvement:

  1. Intellectual Property & Innovation:
    No patents filed yet; transitioning her research into patentable therapies or commercial applications would increase its societal and economic impact.

  2. Leadership Roles:
    While active in research, taking on editorial or scientific leadership positions would enhance her academic visibility and influence.

  3. Internationalization:
    She would benefit from developing international collaborations or fellowships to diversify her research scope and increase global reach.

  4. Industry Engagement:
    Engaging in consultancy or biotech partnerships can further the translational impact of her regenerative strategies.

🎓 Education:

Dr. Takejima’s educational journey began with a Doctor of Medicine (MD) degree from the Pontifical Catholic University of Paraná (PUCPR), Brazil. Her passion for research led her to pursue a Doctorate (PhD) in Health Sciences/Medicine, also at PUCPR. Her doctoral thesis focused on the use of biologically active materials such as the amniotic membrane and stem cells to enhance wound healing. Throughout her academic training, she demonstrated a strong commitment to translational medicine by integrating basic science with clinical practice. During her PhD, she engaged in experimental models involving stem cell therapy and tissue engineering, which laid the groundwork for her current postdoctoral research. Her educational path reflects both depth and specialization in the biomedical sciences, particularly in regenerative medicine and cellular therapies.

💼 Experience:

Dr. Aline Takejima has over a decade of experience in medical and scientific fields, balancing her role as a physician with that of a postdoctoral researcher. Her clinical background informs her research, particularly in areas of wound healing and regenerative medicine. At PUCPR, she contributes to the Wound Healing Research Group, where she is involved in designing and conducting animal model studies to test the effects of biomaterials and stem cells. Her multidisciplinary research integrates immunology, histopathology, and molecular biology. With nine peer-reviewed publications and participation in collaborative research, she has become a respected contributor to the field. Though early in her research career, her trajectory shows a steady rise, marked by evidence-based outcomes and a commitment to innovation. Her goal is to bridge clinical challenges with regenerative solutions that can be implemented in real-world medical practice.

🔬 Research Focus:

Dr. Takejima’s research focuses on regenerative strategies for wound healing, utilizing biomaterials and stem cells. Her work primarily explores the application of amniotic membrane, Wharton’s jelly, and bone marrow-derived mononuclear stem cells in treating complex or chronic skin wounds. Using experimental models in rats and rabbits, she evaluates histological recovery, inflammation modulation, and tissue regeneration. A significant aspect of her research is understanding how these materials promote healing through paracrine effects rather than direct integration, offering a safer and scalable pathway to clinical application. Additionally, her work extends to cardiac and tracheal tissue repair, emphasizing the versatility of these regenerative approaches. The translational nature of her research bridges laboratory discoveries with potential bedside applications, positioning her at the forefront of cellular therapy and biomaterials science.

📚 Publications Top Notes:

  1. 🧠 Wharton’s Jelly Bioscaffolds Improve Cardiac Repair with Bone Marrow Mononuclear Stem Cells in Rats – Journal of Functional Biomaterials, 2025

  2. 🧫 The effects of decellularized amniotic membrane and Wharton’s jelly on the healing of experimental skin wounds in rats – Tissue Barriers, 2025

  3. ❤️ Bone-marrow mononuclear cells and acellular human amniotic membrane improve global cardiac function… – Anais da Academia Brasileira de Ciências, 2024

  4. 🫁 Tracheal regeneration with acellular human amniotic membrane and 15d-PGJ2 nanoparticles in rabbits – Anais da Academia Brasileira de Ciências, 2023

  5. 🧬 Acellular Biomaterials + Autologous Stem Cells Improve Wound Healing via Paracrine Effects – Biomedicines, 2023

  6. 💉 Decellularized Amniotic Membrane Solubilized with Hyaluronic Acid in Wound Healing – Annals of Biomedical Engineering, 2022

  7. 🧪 Role of Mononuclear Stem Cells and Decellularized Amniotic Membrane in Skin Wounds – Tissue Barriers, 2022

  8. 🏥 Trauma hepático: epidemiologia de cinco anos… – Revista do Colégio Brasileiro de Cirurgiões, 2008

🧾 Conclusion:

Dr. Aline Luri Takejima is an outstanding candidate for the Women Researcher Award. Her academic profile demonstrates a strong foundation in regenerative medicine with significant contributions to wound healing research. Her commitment to applying biological therapies in clinical contexts shows both depth and innovation. As a woman scientist in a competitive field, she exemplifies leadership, dedication, and potential. With further growth in global engagement and innovation strategy, Dr. Takejima is poised to become a future leader in regenerative biomedical research.

Alaka Sahoo | Immunology Cellular Interactions | Young Researcher Award

Published on by Cell Biologist

Mrs. Alaka Sahoo | Immunology Cellular Interactions | Young Researcher Award

Mrs. Alaka Sahoo, Siksha’O’ Anusandhan University, India

Dr. Alaka Sahoo is a dedicated young researcher in the field of Biotechnology with a focus on translational and clinical research. She holds a Ph.D. in Biotechnology from Siksha ‘O’ Anusandhan University, Odisha, with a CGPA of 8.90. With over 17 publications, including 11 research articles and 3 high-impact reviews, Dr. Sahoo has significantly contributed to oral disease therapeutics and antimicrobial studies. She demonstrates expertise in multi-omics analysis, drug discovery, and natural product-based therapy. A recipient of prestigious awards such as the Lalchand Women Entrepreneurs Award (2024), she is also a life member of reputed organizations like the British Society for Antimicrobial Chemotherapy. Her innovative approach to disease management using phytochemicals and peptides sets her apart as a rising talent in biomedical research.

Publication Profile: 

Google Scholar

Scopus

Orcid

✅ Strengths for the Award:

  1. Strong Publication Record:

    • 17 publications including 11 original research, 3 reviews, and 2 book chapters, showcasing depth and breadth.

    • 7 papers as first or corresponding author—indicating independent research capability.

    • Research in high-impact journals like Frontiers in Microbiology, Journal of Ethnopharmacology, Nanomaterials, and Chemistry & Biodiversity.

  2. Innovative & Multidisciplinary Research:

    • Integrates multi-omics, computational modeling, clinical dermatology, and natural products.

    • Focus on oral inflammatory diseases, antimicrobial peptides, and drug delivery systems.

  3. Academic Excellence & Research Training:

    • Ph.D. with 8.90 CGPA, and M.Sc. with 87.07% marks.

    • Expertise in BSL-2+ lab work, PCR, ELISA, microbial culture, and molecular docking.

  4. Awards & Recognition:

    • Lalchand Women Entrepreneurs Award (2024).

    • MSME-Idea Hackathon Innovation Award, Govt. of India.

  5. Global and National Engagement:

    • Life member of the British Society for Antimicrobial Chemotherapy (UK).

    • Demonstrates leadership in science entrepreneurship and women in research.

🛠️ Areas for Improvement:

  1. Expanded International Collaboration:

    • Building long-term research partnerships with international labs could increase global visibility.

  2. Patent/Technology Transfer Efforts:

    • While publications are strong, translating research into patents or commercial products will further strengthen applied impact.

  3. Focused Project Leadership:

    • Leading large interdisciplinary projects or acquiring independent grants will showcase funding leadership.

🎓 Education:

Dr. Alaka Sahoo has pursued a progressive academic path in Biotechnology. She earned her Ph.D. in Biotechnology from the School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan Deemed University, Odisha, completing her research with a notable 8.90 CGPA. Her thesis focused on “Therapeutic Opportunities for Oral Lichen Planus: An Integrated Multi-Omics Approach to Drug Discovery” under the guidance of Prof. (Dr.) Maitreyee Panda. Prior to this, she completed her M.Sc. in Biotechnology (87.07%) from the College of Basic Science and Humanities, OUAT, Bhubaneswar in 2018 and a B.Sc. in Biotechnology with distinction (75%) from Ramadevi Women’s College, Utkal University in 2016. Her academic journey showcases a strong foundation in both theoretical and applied aspects of biosciences.

💼 Experience:

Dr. Alaka Sahoo brings rich hands-on research experience in clinical and experimental biotechnology. She is skilled in BSL-2+ lab practices, molecular techniques like PCR, gel electrophoresis, microbial culture, ELISA-based diagnostics, and bioinformatics. Her doctoral work integrated multi-omics and computational biology to study inflammatory oral diseases, and her postdoctoral research spans drug delivery and antimicrobial drug discovery. As first or corresponding author in 7 out of 17 publications, she has led collaborative studies with both national and international partners. Dr. Sahoo’s cross-disciplinary knowledge in microbiology, pharmacology, and nanomedicine enhances her problem-solving abilities, making her a versatile researcher. Her ability to bridge clinical dermatology with biotechnology research positions her as an impactful contributor in both healthcare and academic environments.

🏆 Awards & Honors:

Dr. Alaka Sahoo has received notable accolades for her innovation and leadership in science. In 2024, she was awarded the Lalchand Women Entrepreneurs Award by the Odisha Corporate Foundation, recognizing her outstanding contributions in biotech innovation. She also earned the MSME-Idea Hackathon 3.0 (Women) Innovation Award by the Government of India, honoring her practical scientific advancements with societal impact. These awards reflect her dedication to translational research and her vision to develop cost-effective, natural therapies. Dr. Sahoo is also a life member of two esteemed organizations: the British Society for Antimicrobial Chemotherapy (UK) and Bioclues Innovation, Research and Development (India). Her achievements signify her rising prominence in the field and her commitment to addressing public health challenges through integrative research.

🔬 Research Focus:

Dr. Alaka Sahoo’s research focuses on oral inflammatory diseases, natural product therapeutics, and insect-derived peptides as alternatives to conventional antimicrobials. Her Ph.D. thesis explored multi-omics approaches for drug discovery in Oral Lichen Planus, integrating in vitro, in silico, and clinical data. Her work spans immunomodulation, anti-inflammatory drug screening, and nanodrug delivery systems, with cross-functional expertise in dermatology, pharmacology, and microbiology. She combines computational modeling, molecular docking, and wet-lab validation to develop target-specific therapies. Her studies on biofilm inhibition, antifungal peptides, and phytosteroids hold promise for tackling antimicrobial resistance. Through collaborations across academia and healthcare, she aims to translate her lab findings into clinically viable solutions. Her contributions to systematic reviews and molecular simulations further demonstrate her analytical rigor and commitment to evidence-based research.

📚 Publications Top Notes:

  1. 📘 Experimental and clinical trial investigations of phytoextracts in Oral Lichen Planus: A systematic review – J Ethnopharmacol (2022)

  2. 🐞 Insect-derived antimicrobial peptides as novel anti-biofilm agents: A systematic review – Front. Microbiol. (2021)

  3. 💊 Ultraflexible liposome nanocargo for dermal drug delivery – Nanomaterials (2021)

  4. 🌿 Phytochemicals for Oral Lichen Planus: A multi-omics and experimental study – Chem Biodivers (2025)

  5. ⚗️ Carbohydrate-derived N-benzyl aminocyclopentitols with anticancer properties – Carbohydr Res. (2025)

  6. 🧬 Target-specific screening of anti-inflammatory phytosteroids using molecular docking – Steroids (2025)

  7. 🧪 Insect-derived antifungal peptides in Candida management – Int. J. Mol. Sci. (2025)

  8. 🧫 Azo-coumarin-Co(II)-galangin hybrids for multipotential activities – J. Biomol. Struct. Dyn. (2024)

  9. 🧒 Pediatric dermatology case analysis in Eastern India – Indian J. Paediatr. Dermatol. (2024)

  10. 🔬 Schiff/Mannich coumarin derivatives: Antibacterial and anti-biofilm evaluation – RSC Adv. (2024)

🧾 Conclusion:

Dr. Alaka Sahoo is highly suitable for the Research for Young Researcher Award. Her multi-disciplinary expertise, robust research record, and recognition through national awards highlight her as a promising early-career scientist. She combines academic rigor with innovation, and her work has meaningful implications for public health, especially in oral disease therapy, biofilm inhibition, and phytochemical-based drug development.

Basavaraj Vastrad | Gene Regulation Epigenetics | Best Researcher Award

Published on by Cell Biologist

Dr. Basavaraj Vastrad | Gene Regulation Epigenetics | Best Researcher Award

Dr. Basavaraj Vastrad, KLE College of Pharamac, Gadag, karanataka 582101, India

Dr. Basavaraj Vastrad is a distinguished Indian scientist specializing in pharmaceutical biotechnology and bioinformatics. With over 15 years of research experience, his work bridges cutting-edge genomics, next-generation sequencing (NGS), and computational biology to uncover genetic underpinnings of complex diseases like Alzheimer’s, diabetes, schizophrenia, and various cancers. He holds a Ph.D. in Biochemistry from Kuvempu University and a Master’s in Pharmaceutical Biotechnology from JSS College of Pharmacy. A prolific researcher, Dr. Vastrad has contributed to over 25 impactful publications in reputed international journals. His collaborative efforts with interdisciplinary teams have yielded novel insights and molecular targets for diseases with high clinical burden. Recognized for his methodical approach and academic excellence, Dr. Vastrad has emerged as a thought leader in bioinformatics-driven drug discovery and disease modeling. With a deep commitment to translational research, he continues to shape the scientific understanding of human health and disease.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Extensive Research Contributions
    Dr. Vastrad has published over 25 high-quality research articles, many in international, peer-reviewed, indexed journals. His work spans crucial fields including bioinformatics, genomics, neurodegenerative diseases, cardiovascular disorders, and reproductive health.

  2. Focus on Translational Research
    His research directly addresses major global health concerns—Alzheimer’s, Huntington’s, diabetes, PCOS, schizophrenia, and cardiovascular diseases—using next-generation sequencing (NGS) and computational biology. This demonstrates not only scientific depth but also clinical relevance.

  3. Strong Bioinformatics Expertise
    Dr. Vastrad applies state-of-the-art bioinformatics tools and techniques to identify novel biomarkers, therapeutic targets, and disease-related pathways, offering substantial contributions to personalized medicine and drug discovery.

  4. Solid Foundation in Biochemistry and Biotechnology
    With a Ph.D. in Biochemistry and a Master’s in Pharmaceutical Biotechnology, he brings a robust interdisciplinary background that supports a holistic approach to research problems.

  5. Experience in Microbial Biotechnology and SSF
    His earlier work on solid-state fermentation (SSF) for antibiotic production from agro-industrial waste reflects his ability to integrate sustainability with industrial biotechnology.

  6. Collaborative and Multidisciplinary Approach
    His collaborations with researchers across domains (pharmacology, genetics, medicine, and bioinformatics) showcase a team-oriented and integrative research mindset.

⚠️ Areas for Improvement:

  1. International Recognition and Grants
    While his publication record is excellent, securing global research grants, international collaborations, and patents would further enhance his global research standing.

  2. Innovation Translation
    Translating his bioinformatics discoveries into patents, prototypes, or clinical tools would significantly amplify the societal impact of his work.

  3. Leadership in Research Communities
    Serving on editorial boards, leading consortia, or contributing to scientific policy and outreach would help extend his influence in the scientific community.

🎓 Education:

Dr. Basavaraj Vastrad’s academic journey began with a Bachelor’s in Pharmacy from K.L.E’s College of Pharmacy, Hubli under RGUHS, Bangalore, completed in 2003. He pursued his Master of Pharmacy in Pharmaceutical Biotechnology from J.S.S. College of Pharmacy, Ootacamund (affiliated to The Tamil Nadu Dr. M.G.R. Medical University), which he completed in 2006. Driven by his passion for biomedical research, he earned his Ph.D. in Biochemistry from Kuvempu University, Shimoga, in 2013. His academic training is rooted in pharmaceutical sciences, molecular biology, and biotechnological applications, providing him a strong foundation in both experimental and computational research methodologies. Dr. Vastrad’s educational background reflects a harmonious blend of practical pharmaceutical knowledge and bioinformatics expertise—skills he now applies to genomics, drug discovery, and disease pathway elucidation. Each academic milestone laid the groundwork for his prolific research career focused on solving health-related challenges through innovative approaches.

👨‍🔬 Experience:

Dr. Basavaraj Vastrad has an extensive research and teaching experience spanning over a decade, primarily focusing on pharmaceutical biotechnology, solid-state fermentation, and bioinformatics. Early in his career, he specialized in microbial techniques, including antimicrobial assays and sterility testing. He later advanced to complex genomic data analysis using NGS and bioinformatics tools to decode molecular mechanisms behind various human diseases. His contributions have been instrumental in identifying biomarkers and therapeutic targets for disorders such as Alzheimer’s, schizophrenia, cardiovascular diseases, and metabolic syndromes. Collaborating with clinical and academic institutions, he has co-authored several high-impact research papers. He has also mentored junior researchers and contributed to numerous interdisciplinary studies. Dr. Vastrad’s experience in solid-state fermentation has led to optimized antibiotic production using agro-industrial waste, showcasing his ability to translate basic science into practical applications. His work stands out for its scientific rigor, innovative approaches, and potential for real-world clinical impact.

🔬 Research Focus:

Dr. Basavaraj Vastrad’s research is primarily centered around the application of bioinformatics and next-generation sequencing (NGS) to investigate the genetic and molecular basis of complex diseases. His projects have successfully decoded the signaling pathways, biomarkers, and therapeutic targets associated with conditions like Alzheimer’s disease, Huntington’s disease, PCOS, heart failure, endometriosis, schizophrenia, and various cancers. Another aspect of his research explores solid-state fermentation for the optimization of antibiotic production, using agro-industrial waste as a substrate. Dr. Vastrad applies computational tools to perform gene expression profiling, pathway enrichment, molecular docking, and biomarker identification. He also collaborates extensively with clinicians and scientists in integrating bioinformatics findings into potential translational therapies. His focus on data-driven diagnostics and personalized medicine represents a blend of computational science with tangible health outcomes. His goal is to harness bioinformatics for predictive diagnostics, therapeutic development, and a deeper understanding of pathophysiological mechanisms.

📚 Publications Top Notes:

  1. 🔍 Bioinformatics analysis of NGS data to diagnose crucial and novel genes in gestational diabetes mellitus

  2. 🧠 Identification of key genes in Huntington’s disease using NGS and bioinformatics

  3. 🧬 Analysis of Alzheimer’s disease pathways using NGS and computational approaches

  4. 🧘‍♂️ Key gene identification in schizophrenia using NGS-based bioinformatics

  5. 👩‍⚕️ Polycystic ovary syndrome: bioinformatics-based gene pathway identification

  6. ❤️ Myocardial infarction: NGS-driven bioinformatics marker analysis

  7. 👩 Endometriosis biomarkers identified using bioinformatics and NGS

  8. 🌬 Gene expression in idiopathic pulmonary fibrosis via bioinformatics and NGS

  9. 🔬 Molecular markers in pancreatic ductal adenocarcinoma using bioinformatics

  10. 💓 Heart failure: discovery of genes and pathways through NGS data

🧾 Conclusion:

Dr. Basavaraj Vastrad is highly deserving of the Best Researcher Award. His consistent contributions to bioinformatics and pharmaceutical biotechnology, innovative approaches to disease genomics, and impactful publications demonstrate scientific excellence, depth, and relevance. He not only pushes the boundaries of current biomedical knowledge but also aligns his work with pressing healthcare needs.

Dalia Saleh | Cancer Cell Biology | Innovative Research Award

Published on by Cell Biologist

Prof. Dalia Saleh | Cancer Cell Biology | Innovative Research Award

Prof. Dalia Saleh, National Research Centre, Egypt

Dr. Dalia Osama Abd El Fattah Saleh is a distinguished pharmacologist and professor at the National Research Centre, Cairo, Egypt. With a career spanning over two decades in academic and pharmaceutical research, she specializes in molecular pharmacology, experimental therapeutics, and drug development. She earned her Ph.D. and M.Sc. in Pharmacology from Cairo University, where she also completed her undergraduate pharmacy degree with honors. Dr. Saleh’s prolific contributions to science are reflected in her extensive publication record, focusing on novel therapeutic strategies against various toxicological, metabolic, and inflammatory disorders. Her collaborative efforts have led to advancements in drug signaling pathways, phytochemical pharmacology, and nanotechnology-based delivery systems. Recognized nationally for her innovation, she has received several prestigious awards. Dr. Saleh continues to shape pharmacological research through her dedication to translational science, mentorship, and participation in international seminars and training programs.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  • Extensive Academic Background: Holds a Ph.D., M.Sc., and B.Sc. in Pharmacology from Cairo University, with a clear focus on endocrine and vascular pharmacology from early in her career.

  • Distinguished Research Record: Authored over 25+ high-impact publications in peer-reviewed journals including Scientific Reports, Toxicology Reports, Biochemistry and Cell Biology, and Environmental Science and Pollution Research.

  • Novel Scientific Contributions:

    • Explores molecular pharmacology through cutting-edge therapeutic approaches like AMPK/mTOR signaling, Nrf2/NF-κB modulation, and natural compound pharmacodynamics.

    • Studies involve both synthetic and phytochemical-based interventions, representing a hybrid and innovative research style.

  • Awards and Recognition:

    • National recognition for her research quality and productivity by the National Research Centre, with awards received in 2015 and 2020.

    • Ranked 24th in the institution for publication volume in 2014—an indicator of sustained output.

  • Global Exposure: Participated in professional training programs at King’s College London, enhancing her knowledge in clinical drug development and data management—an asset for interdisciplinary and translational research.

  • Leadership and Longevity: Promoted through all academic ranks at NRC, from Research Assistant to Professor, demonstrating not only competence but leadership and mentorship over time.

Areas for Improvement:

  • Clinical Translation: While the preclinical research is extensive, initiating clinical trials or translational studies would further strengthen the real-world applicability of her findings.

  • Global Visibility: Although trained internationally, more international speaking engagements, keynote invitations, or editorial roles could enhance global recognition.

  • Interdisciplinary Projects: Expanding collaborations across fields such as bioinformatics or biotechnology could amplify the innovation aspect of her work.

🎓 Education:

Dr. Dalia Saleh obtained all her academic degrees from Cairo University’s esteemed Faculty of Pharmacy. She was awarded her Ph.D. in Pharmacology in 2012 for her thesis examining estrogen’s vascular effects in insulin-resistant, ovariectomized rats. Earlier, she earned her M.Sc. in 2009 with research on rosiglitazone’s effects in streptozotocin-induced vascular changes. Her academic journey began with a B.Sc. in Pharmacy in 2002, graduating with distinction and honors. Her strong educational foundation laid the groundwork for her innovative and interdisciplinary research spanning molecular pharmacology, toxicology, and metabolic disorders. Through continuous professional development, including modules at King’s College London, Dr. Saleh stays aligned with global standards in pharmacological science and clinical drug development. Her educational background combines academic excellence with practical research expertise, making her well-equipped to address complex biomedical challenges.

👩‍🔬 Experience:

Dr. Dalia Saleh has built a progressive research career at Egypt’s National Research Centre, beginning as a Research Assistant in 2003. Over the years, she rose through the ranks to become a Professor in 2022. She previously held positions as Researcher (2012–2017) and Assistant Professor (2017–2022). Throughout her tenure, she has actively contributed to preclinical pharmacology research, focusing on inflammation, neuroprotection, metabolic diseases, and organ toxicity. Her interdisciplinary approach integrates pharmacodynamics, molecular signaling, and therapeutic intervention studies using both synthetic and natural compounds. She has led numerous studies that explore drug mechanisms at cellular and systemic levels, often employing rodent disease models. Dr. Saleh’s active participation in international training (e.g., at King’s College London) highlights her global engagement and commitment to continuous learning. Her career reflects not only research productivity but also leadership in collaborative scientific initiatives and mentoring of emerging researchers.

🏆 Awards & Honors:

Dr. Dalia Saleh has received multiple accolades that underscore her impact in the field of pharmacology. She was honored with the 2020 Scientific Pioneers Award and the 2015 Scientific Encouragement Award from Egypt’s National Research Centre (NRC), recognizing her outstanding research contributions. In 2014, she received institutional recognition for both her high publication output (ranked 24th NRC-wide) and for publishing in a high-impact journal (impact factor 4.067). These achievements highlight her consistent scientific productivity and influence in biomedical research. Dr. Saleh’s awards reflect a career driven by innovation, rigor, and dedication to solving pressing health issues. Her work continues to be widely cited and applied in translational pharmacology, securing her reputation as a leading figure in her discipline. She remains an inspiration to peers and students alike, with a legacy of both scientific excellence and mentorship.

🔬 Research Focus:

Dr. Dalia Saleh’s research is rooted in experimental pharmacology, with an emphasis on cell signaling pathways, drug discovery, and natural compound pharmacodynamics. She investigates molecular mechanisms underlying chronic diseases such as diabetes, hepatic and renal injury, neurodegeneration, and inflammatory disorders. A recurring theme in her work is the modulation of key signaling axes (e.g., AMPK/mTOR, NF-κB, PI3K/Akt) in mitigating organ toxicity and disease progression. Her recent studies explore the pharmacological potential of phytochemicals, drug hybrids, and nanoformulations in preclinical models. Dr. Saleh also examines gender-specific pathophysiology, as seen in her Ph.D. research on estrogen’s role in vascular dysfunction. She actively integrates biochemical, histological, and behavioral endpoints to ensure translational relevance. By bridging traditional medicine and molecular pharmacology, her work contributes to next-generation therapeutics and precision medicine. Her research has both national and global impact, frequently published in high-tier journals and cited in clinical research discussions.

📚 Publications Top Notes:

  1. 🧬 Eugenol alleviates acrylamide-induced testicular toxicity via AMPK/pAKT/mTOR signaling – Scientific Reports, 2024

  2. 💊 Trimetazidine protects against cisplatin-induced neuropathy via AMPK and Nrf2 pathways – Biochemistry and Cell Biology, 2023

  3. 🧪 Chromone-thiazolopyrimidine hybrids inhibit TNF-α, IL-6, and PGE2 – Polycyclic Aromatic Compounds, 2023

  4. 🧻 Chrysin counters cyclophosphamide-induced cystitis via STAT-3 and NF-κB inhibition – Chemico-Biological Interactions, 2023

  5. 🩺 Linagliptin and L-arginine synergize in hyperacidity via EP4 upregulation – Naunyn-Schmiedeberg’s Archives of Pharmacology, 2023

  6. 🧠 L-arginine protects against hepatic encephalopathy via anti-apoptotic mechanisms – Environmental Science and Pollution Research, 2023

  7. 🌿 Calotropis procera seed oil shows anti-inflammatory and antiparasitic activity – Arabian Journal of Chemistry, 2022

  8. 🧫 Olmesartan mitigates diabetic nephropathy through TLR4/P38-MAPK modulation – European Journal of Pharmacology, 2022

  9. 🌱 Anti-fibrotic activities of Plumbago species in liver fibrosis models – Scientific Reports, 2022

  10. 🐟 Omega-3 fatty acids protect against doxorubicin-induced liver damage – Saudi Journal of Biological Sciences, 2022

Conclusion:

Dr. Dalia O. Saleh is highly suitable for the Best Researcher Award based on her prolific scientific contributions, consistent academic progression, and commitment to impactful pharmacological research. Her strength lies in combining rigorous mechanistic studies with applied therapeutic exploration, especially in inflammation, oxidative stress, and natural product pharmacology.

Noureddine Allouche | Molecular Mechanisms Signaling | Best Research Article Award

Published on by Cell Biologist

Prof. Noureddine Allouche | Molecular Mechanisms Signaling | Best Research Article Award

Prof. Noureddine Allouche , Faculty of Sciences of Sfax, University of Sfax , Tunisia

Professor Noureddine Allouche, born in 1971, is a Full Professor of Chemistry at the Faculty of Sciences of Sfax (FSS), Tunisia. He is the Head of the Natural Substances Team in the Laboratory of Organic Chemistry. With over 150 peer-reviewed publications, an h-index of 35, and more than 4500 citations, he is recognized for his impactful research on natural products and environmental valorization. He has led and contributed to multiple national and European research projects, including FP7, H2020, Erasmus+, and ARIMNET. His work focuses on extraction, isolation, and bioactivity of plant-based compounds and sustainable management of industrial waste. Prof. Allouche has supervised 20 Ph.D. theses and 42 M.Sc. students, contributing significantly to scientific advancement in Tunisia and beyond. He is also involved in applied research in green chemistry and cosmetic sciences. His collaborative work and leadership have earned him recognition in the academic and research communities.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. High Research Productivity and Impact

    • Over 150 peer-reviewed scientific articles with a h-index of 35 and 4,500+ citations, which reflect sustained academic influence and quality.

    • Contributor to top-tier journals such as Plants, Biomolecules, and Molecules.

  2. Strong Focus on Societal Relevance

    • Work addresses critical environmental issues such as olive mill waste valorisation, bioconversion, and sustainable resource use.

    • Research applied in green chemistry, natural product-based pharmaceuticals, and eco-cosmetics.

  3. International Collaboration and Leadership

    • Coordinator of six major European and international research projects (FP7, H2020, Erasmus+, ARIMNET).

    • Active partnerships with institutions in France, Germany, and the Mediterranean region, showcasing leadership in multidisciplinary and multinational research.

  4. Methodological Rigor and Innovation

    • Use of advanced analytical techniques (e.g., HPLC-HESI-MS/MS, LC-MS/MS, ESI-MS/MS).

    • Integration of green technologies for natural substance extraction.

  5. Mentorship and Academic Development

    • Supervised 20 Ph.D. theses (plus 4 ongoing), 42 Master’s theses, and numerous diploma projects, especially in applied fields like cosmetic science.

🛠️ Areas for Improvement:

  1. Broader International Recognition

    • While highly active in regional and EU collaborations, increased visibility in global North America/Asia-led consortia or global forums could enhance recognition.

  2. Science Communication and Outreach

    • Publishing in public engagement platforms or delivering talks/webinars to non-specialist audiences could expand the impact of his research beyond academia.

  3. Open Access and Data Sharing

    • Encouraging open data practices and reproducibility of extraction and formulation protocols could enhance scientific transparency and citations.

🎓 Education:

Professor Noureddine Allouche earned his Ph.D. in Chemistry from the University of Sfax between 2000 and 2005, focusing on the treatment and valorisation of olive mill waste, a subject that would lay the foundation for his future research career. Following this, he undertook a prestigious postdoctoral training (2006–2007) at the Institute of Natural Products Chemistry of CNRS in Gif-sur-Yvette, France, enhancing his expertise in natural substances and analytical chemistry. His academic foundation was built on rigorous training in organic chemistry, natural products, and environmental biotechnology. These experiences equipped him with robust research methodologies and an interdisciplinary approach, especially in the extraction and biological evaluation of phytochemicals. His educational path reflects a strong commitment to green and sustainable chemistry, positioning him well for leading high-impact research on natural product development and eco-friendly industrial applications.

💼 Experience:

Professor Allouche has over 20 years of academic and research experience. He currently leads the Natural Substances Team at the Faculty of Sciences of Sfax and supervises a group of over 20 researchers. He has played a vital role in international research collaborations, serving as the national coordinator of six European-funded projects under FP7, ARIMNET, H2020, Erasmus+, and PHC-Maghreb. His experience also includes participation in the INCO-MED project on detoxification and recovery from olive mill wastewater. Prof. Allouche has an extensive mentoring portfolio, having supervised 20 Ph.D. theses (with 4 ongoing) and 42 M.Sc. students. He has authored 150+ articles, two book chapters, and holds two patents. His career reflects a blend of scientific innovation and applied industrial research, particularly in green technologies, bioactive compounds, and waste valorisation. He is also a regular collaborator with European institutions, reflecting his global outlook and leadership in sustainable science.

🔍 Research Focus:

Prof. Noureddine Allouche’s research centers on natural substances chemistry, green extraction methods, and biotechnological valorisation of industrial wastes, particularly from agro-food sources. He has made significant contributions to the identification and biological evaluation of bioactive compounds such as phenolics, flavonoids, and essential oils. His team is particularly active in analyzing plant extracts for their antioxidant, antimicrobial, cytotoxic, and anti-aging activities, often employing advanced techniques like HPLC, LC-MS/MS, and ESI-MS/MS. Another pillar of his work includes developing biopesticides and bio-cosmetics through green and eco-sustainable approaches. He contributes to nanoformulation research and the design of nature-based products aligned with circular economy principles. His interdisciplinary projects bridge chemistry, pharmacology, environmental science, and cosmetic formulation, making his research highly relevant for addressing current scientific and industrial challenges. His recent involvement in projects like GreenCosmIn and 25MAG23 reflects his leading role in European research on sustainable innovation.

📚 Publications Top Notes:

  1. 🌿 HPLC-HESI-MS/MS Analysis of Phenolic Compounds from Cynoglossum tubiflorus Leaf Extracts (Plants, 2024)

  2. 🫒 Intensification of Biophenols Extraction Yield from Olive Pomace Using Innovative Green Technologies (Biomolecules, 2022)

  3. 🌸 Antioxidant and Antimicrobial Activities of Erodium arborescens Extracts Characterized by LC-HESI-MS² (Molecules, 2022)

  4. 🌿 ESI-MS/MS Analysis of Aeonium arboreum Leaf Extracts and Evaluation of Antioxidant and Antimicrobial Activities (Molecules, 2021)

  5. 🍇 Novel Natural Products for Healthy Ageing from Mediterranean Diet – The MediHealth Project (Molecules, 2018)

🧾 Conclusion:

Professor Noureddine Allouche stands out as a highly qualified and deserving candidate for the Best Research Article Award. His impressive record in sustainable chemistry, natural products research, international project coordination, and scholarly mentorship underlines his academic excellence and real-world impact. His research directly contributes to health, environmental sustainability, and circular economy principles, aligning well with the goals of high-impact, solution-driven science.

Guannan Ma | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Ms. Guannan Ma | Microbial Cell Biology | Best Researcher Award

Ms. Guannan Ma , Zhejiang Key Laboratory of Digital Technology in Medical Diagnostics , China

Guannan Ma is a seasoned biomedical researcher and medical manager based in Beijing, China, with over a decade of experience in molecular biology, genomics, and clinical research. He currently works at DIAN Gene Co., Ltd., where he leads clinical research projects, scientific writing, and patent development. With a strong academic foundation and a passion for translational medicine, he bridges laboratory research and real-world applications in diagnostics and therapeutics. His background includes extensive collaboration with national R&D initiatives and hospital systems, reflecting his ability to manage interdisciplinary projects and mentor junior scientists. Guannan is the co-author of over 15 peer-reviewed SCI papers and multiple patents in the fields of gene editing, DNA data storage, and cancer biology. Fluent in both English and Chinese, he is also certified in Good Clinical Practice (GCP), ensuring ethical and high-quality research standards. His contributions mark him as a strong contender for the Best Researcher Award.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. 📚 Extensive Publication Record

    • Over 15 SCI-indexed publications in top-tier journals such as Redox Biology, Advanced Science, and Genomics Proteomics Bioinformatics with a cumulative impact factor exceeding 60.

  2. 🔬 Interdisciplinary Research Expertise

    • Proven proficiency in multi-omics, CRISPR, genetic engineering, clinical research, and data analysis. His work spans microbiology, genomics, and translational medicine.

  3. 💡 Innovation & Intellectual Property

    • Multiple patents, including breakthrough innovations in DNA storage and cancer biomarker regulation, highlighting strong translational value and originality.

  4. 🌍 International and National Project Leadership

    • Key contributor to national R&D projects (e.g., DNA storage, microbiota gene adaptation) and cross-institutional collaborations.

  5. 📈 Clinical Impact & GCP Certification

    • Designs and executes clinical research supporting product development, demonstrating clear real-world applications.

  6. 👥 Mentorship and Team Leadership

    • Has supervised students, trained staff, and coordinated multicenter studies—showing strong leadership and collaborative aptitude.

🛠 Areas for Improvement:

  1. 🌐 Broader International Exposure

    • While Guannan has studied abroad, further global collaborations or fellowships (e.g., Horizon Europe, NIH, or WHO research programs) could enhance his international recognition.

  2. 📣 Science Communication & Outreach

    • Increasing science communication efforts (e.g., webinars, social media, TEDx talks) would help raise visibility of his research beyond academic audiences.

  3. 🔄 Continuous Skill Upgrading

    • Pursuing cutting-edge training in AI-based bioinformatics or clinical trial informatics could keep his expertise aligned with rapidly evolving biomedical tools.

🎓 Education:

Guannan Ma holds a Master of Science degree in Marine Science and Engineering from Tianjin University of Science and Technology (2012–2015), complemented by a year as a visiting Master’s student at Ghent University, Belgium (2014–2015). This dual exposure to domestic and international academic environments provided him with a robust interdisciplinary foundation. At Tianjin University, he developed a solid grasp of molecular biology, environmental genomics, and research methodologies, while his time at Ghent University enriched his perspective on global scientific standards and collaborative innovation. These academic experiences not only honed his technical expertise but also shaped his strong commitment to academic excellence and scientific rigor. His education played a crucial role in shaping his current research path, which integrates cutting-edge biotechnology, clinical research, and bioinformatics, and laid the groundwork for his involvement in high-impact national and international scientific projects.

💼 Experience:

Guannan Ma brings 10 years of diverse research and clinical project experience. Currently, as Medical Manager at DIAN Gene Co., Ltd. (since June 2022), he leads clinical study design, publication development, academic training, and patent filing. Prior to this, he spent over seven years (2015–2022) at the Beijing Institute of Genomics, Chinese Academy of Sciences, where he contributed to national research grants, supervised students, and mastered technologies like CRISPR-Cas9, ELISA, and mouse modeling. His work also included managing large-scale omics data and integrating microbiome, genetic, and metabolomic research. Across both roles, Guannan has demonstrated exceptional project leadership, technical fluency, and collaborative engagement across multi-disciplinary teams. His work has resulted in 15 high-impact SCI publications and multiple innovations in molecular diagnostics, microbial resistance, and gene therapy. With deep roots in both academia and industry, he exemplifies a rare blend of scientific depth, clinical insight, and leadership potential.

🔬 Research Focus:

Guannan Ma’s research focuses on the intersection of molecular biology, genomics, microbiome science, and clinical translation. His core areas include multi-omics data integration (genomics, transcriptomics, and metabolomics), gene editing (CRISPR-Cas9), and the development of diagnostic tools using advanced sequencing technologies such as Nanopore. He is particularly interested in antimicrobial resistance, host-pathogen interactions, and precision medicine strategies for diseases like cancer and infectious disorders. His recent contributions at DIAN Gene Co., Ltd. include initiating and leading clinical trials to support product indications, conducting systematic literature reviews, and ensuring the scientific integrity of marketing content. Guannan’s patent portfolio spans DNA data storage systems and microRNA-mediated cancer pathways, reflecting his commitment to high-impact innovation. He also supports scientific communication through English/Chinese academic writing and staff training. His work bridges scientific discovery and clinical application, driving forward patient-centered solutions rooted in cutting-edge genomics and biotechnology.

📚 Publications Top Notes:

  1. 🧫 Redox imbalance in disease: Role of redox biology in clinical research – Redox Biology, 2024

  2. 👶 Exploring biomarkers in pediatric diagnostics – Frontiers in Pediatrics, 2025

  3. 💊 Pharmacogenomics in personalized medicine – Pharmacogenomics and Personalized Medicine, 2024

  4. 🧪 Nanomaterials and biomedical advancements – Advanced Science, 2024

  5. 🦠 Candida auris strain characterization from bloodstream infections – Clinics, 2024

  6. 🧬 Probiotics in elderly pneumonia patients: Gut flora insights – Medicine, 2023

  7. 🔍 Digital twin systems for high-precision optical engineering – Preprints.org, 2023

  8. 🎵 Music therapy effectiveness in ASD children: Meta-analysis – Frontiers in Psychiatry, 2022

  9. 💾 DNA data storage: Encoding-decoding techniques overview – CCF Trans. on High Performance Computing, 2022

  10. 🧫 Genomic epidemiology of resistant Klebsiella pneumoniae strains – Genomics Proteomics Bioinformatics, 2022

🧾 Conclusion:

Guannan Ma is an exceptionally strong candidate for the Best Researcher Award. His balanced combination of scientific depth, innovation, and applied clinical relevance stands out. With a publication history that demonstrates both quality and breadth, contributions to national innovation priorities, and a proven track record of mentorship and teamwork, he embodies the qualities of a high-impact, future-forward researcher. By extending his global footprint and amplifying public engagement, Guannan Ma has the potential to become a key thought leader in life sciences and medical biotechnology.